Normal view MARC view ISBD view

Lung Cancer : translational and emerging therapies / edited by Kishan J. Pandya, Julie R. Brahmer, Manuel Hidalgo. - New York : Informa Healthcare, c2007. - viii, 265 p. : ill. ; 24 cm. - Translational medicine series ; 3 .

Includes bibliographical references and index.

Molecular biology of lung cancer as the basis for targeted therapy / Oliver Gautschi ... [et al.] -- Early clinical trial design issues: patient populations, end points, and barriers / Janet E. Dancey -- Antiangiogenic therapy for lung cancer: small-molecule inhibitors / Nithya Ramnath and Alex A. Adjei -- Antiangiogenic therapy for lung cancer: antibodies and other novel agents / Sarita Dubey and Ravi Salgia -- Epidermal growth factor receptor inhibition in non-small cell lung cancer / Antonio Jimeno and Manuel Hidalgo -- Epidermal growth factor receptor targeted therapy--markers of sensitivity and response / Rafal Dziadziuszko, Barbara Szostakiewicz, and Fred R. Hirsch -- Other novel targeted therapies in lung cancer / Kyriakos P. Papadopoulos and Anthony W. Tolcher -- Lung cancer vaccines / Cheryl Ho ... [et al.] -- Advances in chemoradiation treatment of locoregionally advanced non-small cell lung cancer / Michael T. Milano and Yuhchyau Chen -- Advances in the treatment of brain metastases / Malika L. Siker and Minesh P. Mehta -- Recent advances in imaging for lung cancer / Shweta Bhatt, Kristopher M. Skwarski, and Vikram S. Dogra.

ISBN: 9780849390210 0849390214

LCCN: 2007007228

Nat. Bib. No.: GBA712158 bnb

Nat. Bib. Agency Control No.: 101299648 DNLM 013672538 Uk

Subjects--Topical Terms:
Lungs--Cancer--Chemotherapy.
Lungs--Cancer--Treatment--Technological innovations.
Lungs--Cancer--Molecular aspects.
Lung Neoplasms--drug therapy.
Antineoplastic Agents--therapeutic use.

LC Class. No.: RC280.L8 / L827 2007

Dewey Class. No.: 616.99/42406